EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The role of the adenosinergic pathway in resistance to hypomethylating agents in patients with high‐risk myelodysplastic syndromes

George Vrachiolias iD, Eleftheria Lamprianidou, Athanasios Tasis iD, Theodoros Spyropoulos iD, Despoina Dimitriou iD, Chryssa Kymparidou, Christina Misidou iD, Konstantinos Liapis iD, Emmanouil Spanoudakis iD, Maria Koffa iD, Menelaos Papoutselis, Iliana Stamatiou iD und 4 weitere

British Journal of Haematology · 2026-11 · 209 (5) · 2335-2340

DOI: 10.1111/bjh.70778 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 26.08.2026. Verfasst von George Vrachiolias und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

adenosinergic pathwayectonucleotidaseshypomethylating agentshypoxic tumoursimmunosuppressionmyelodysplastic syndrome

Autor:innen und Institutionen

  • Department of Haematology, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece.
  • Department of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece.
  • Gustave Roussy, Villejuif, France.
  • Memorial Sloan Kettering Cancer Center, New York, New York, USA.

ORCID-Profile: George Vrachiolias, Athanasios Tasis, Theodoros Spyropoulos, Despoina Dimitriou, Christina Misidou, Konstantinos Liapis, Emmanouil Spanoudakis, Maria Koffa, Iliana Stamatiou, Elsa Bernard, Ioannis Mitroulis

Zitieren

APA

Vrachiolias, G., Lamprianidou, E., Tasis, A., Spyropoulos, T., Dimitriou, D., Kymparidou, C., Misidou, C., Liapis, K., Spanoudakis, E., Koffa, M., Papoutselis, M., Stamatiou, I., Bernard, E., Papaemmanuil, E., Mitroulis, I., & Kotsianidis, I. (2026). The role of the adenosinergic pathway in resistance to hypomethylating agents in patients with high‐risk myelodysplastic syndromes. British Journal of Haematology, 209(5), 2335-2340. https://doi.org/10.1111/bjh.70778

Vancouver

Vrachiolias G, Lamprianidou E, Tasis A, Spyropoulos T, Dimitriou D, Kymparidou C, et al. The role of the adenosinergic pathway in resistance to hypomethylating agents in patients with high‐risk myelodysplastic syndromes. British Journal of Haematology. 2026;209(5):2335-2340. doi:10.1111/bjh.70778

BibTeX
@article{Vrachiolias2026,
  author = {Vrachiolias, George and Lamprianidou, Eleftheria and Tasis, Athanasios and Spyropoulos, Theodoros and Dimitriou, Despoina and Kymparidou, Chryssa and Misidou, Christina and Liapis, Konstantinos and Spanoudakis, Emmanouil and Koffa, Maria and Papoutselis, Menelaos and Stamatiou, Iliana and Bernard, Elsa and Papaemmanuil, Elli and Mitroulis, Ioannis and Kotsianidis, Ioannis},
  title = {The role of the adenosinergic pathway in resistance to hypomethylating agents in patients with high‐risk myelodysplastic syndromes},
  journal = {British Journal of Haematology},
  year = {2026},
  volume = {209},
  number = {5},
  pages = {2335--2340},
  doi = {10.1111/bjh.70778}
}
Kostenlos starten →